News
We recently published a list of 10 Best Medical Stocks to Buy According to Billionaires. In this article, we are going to ...
GreensKeeper Asset Management, an investment management company, released its first quarter 2025 investor letter. A copy of ...
Providing deeper insights, analysts have established 12-month price targets, indicating an average target of $477.08, along with a high estimate of $512.00 and a low estimate of $405.40. Marking an ...
Guggenheim initiated coverage of Elevance Health (ELV) with a Buy rating and $518 price target The firm launched coverage on 11 healthcare ...
Mizuho raised the firm’s price target on Elevance Health (ELV) to $505 from $455 and keeps an Outperform rating on the shares. The firm ...
Shares of Elevance Health, Inc. (NYSE:ELV – Get Free Report) have been given a consensus rating of “Moderate Buy” by the ...
Elevance Health (NYSE ... When compared to others in the Health Care sector, the company faces challenges, achieving a growth rate lower than the average among peers. Net Margin: The company's ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results